Comparison of Early Urinary Continence, Oncological Outcomes, and Postoperative Complications in Retzius-Sparing and Standard Approach Robot-Assisted Radical Prostatectomy
Journal of Laparoendoscopic and Advanced Surgical Techniques, cilt.33, sa.2, ss.150-154, 2023 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 33 Sayı: 2
- Basım Tarihi: 2023
- Doi Numarası: 10.1089/lap.2022.0409
- Dergi Adı: Journal of Laparoendoscopic and Advanced Surgical Techniques
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, MEDLINE
- Sayfa Sayıları: ss.150-154
- Anahtar Kelimeler: robotic surgery, Retzius sparing prostatectomy, urinary incontinence, prostate cancer
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Background: The aim of the study is to compare the results of early urinary continence (UC), pathological results, console time (CT), and perioperative morbidity in patients who underwent transperitoneal robot-Assisted radical prostatectomy (TR-RARP) and Retzius-sparing robot-Assisted radical prostatectomy (RS-RARP) surgeries in the treatment of clinically localized prostate cancer. Methods: A total of 120 patients, 60 (Group 1) with the TR-RALP technique and 60 (Group 2) with the RS-RALP technique, who had no statistical difference in their preoperative demographic data, were selected retrospectively. Perioperative and postoperative data, and continence rates in the first, third and sixth months were compared between the 2 groups. Results: There was no significant difference between the groups in terms of CT, hemoglobin change, and perioperative and postoperative data. There was a statistically significant difference between the 2 groups in favor of RS-RARP in terms of UC in the first and third months, whereas there was no statistically significant difference between the groups at month 6 (P = .001, P = .002, and P = .245, respectively). Conclusion: This study demonstrates that the RS-RARP technique is a promising approach to achieve early continence without compromising oncological principles and without increased complication rates.